C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2011
11/15/2011	CA2372655C Recombinant adenovirus having low pre-existing neutralizing activity
11/15/2011	CA2365592C Herbicide resistant plants comprising epsps
11/15/2011	CA2365196C Chlamydia antigens and corresponding dna fragments and uses thereof
11/15/2011	CA2343979C Human interleukin-b50, therapeutic uses
11/15/2011	CA2296005C Tenebrio antifreeze proteins
11/15/2011	CA2267197C Isolation and use of motoneuronotrophic factors
11/15/2011	CA2262019C Target nucleic acid sequence amplification method
11/15/2011	CA2257851C Modulators of tissue regeneration
11/15/2011	CA2252970C Optimization of cells for endogenous gene activation
11/15/2011	CA2189349C Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
11/15/2011	CA2171761C Eotaxin: eosinophil chemotactic cytokine
11/15/2011	CA2170641C Senescent cell-derived inhibitors of dna synthesis
11/12/2011	CA2740237A1 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof
11/10/2011	WO2011140529A1 Surface markers and uses thereof for rapid stable cell line generation and gene amplification
11/10/2011	WO2011140510A2 Oligonucleotide ligation, barcoding and methods and compositions for improving data quality and throughput using massively parallel sequencing
11/10/2011	WO2011140365A1 Targeted particles comprising landscape phage fusion proteins and heterologous nucleic acid
11/10/2011	WO2011140342A1 Mutations and genetic targets for enhanced l-tyrosine production
11/10/2011	WO2011140329A1 Transgenic plants having increased biomass
11/10/2011	WO2011140279A1 Aav-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
11/10/2011	WO2011140237A2 Process for detection of multidrug resistant tuberculosis using real-time pcr and high resolution melt analysis
11/10/2011	WO2011140187A2 Detecting chromosomal rearrangement
11/10/2011	WO2011140173A1 Detection and treatment of fibrosis
11/10/2011	WO2011140170A1 Immunotherapy using redirected allogeneic cells
11/10/2011	WO2011139920A2 Methylation-specific competitive allele-specific taqman polymerase chain reaction (cast-pcr)
11/10/2011	WO2011139917A1 Modulation of transthyretin expression
11/10/2011	WO2011139911A2 Lipid formulated single stranded rna
11/10/2011	WO2011139854A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
11/10/2011	WO2011139853A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
11/10/2011	WO2011139843A2 Multi-sirna compositions for reducing gene expression
11/10/2011	WO2011139842A2 Nucleic acid compounds for inhibiting fgfr3 gene expression and uses thereof
11/10/2011	WO2011139798A2 Modified pyr/pyl receptors activated by orthogonal ligands
11/10/2011	WO2011139769A2 Immunogenic compositions and methods for treating neoplasia
11/10/2011	WO2011139710A1 Nucleic acid compounds with conformationally restricted monomers and uses thereof
11/10/2011	WO2011139638A2 Enhanced carbon fixation in photosynthetic hosts
11/10/2011	WO2011139629A2 Light targeting molecules and uses thereof
11/10/2011	WO2011139431A1 Maize acc synthase 3 gene and protein and uses thereof
11/10/2011	WO2011139387A1 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
11/10/2011	WO2011139385A2 Genetic signatures in hiv-1 subtype c envelope glycoproteins
11/10/2011	WO2011139336A1 Genome editing of a rosa locus using nucleases
11/10/2011	WO2011139335A1 Genome editing of a rosa locus using zinc-finger nucleases
11/10/2011	WO2011139032A2 Primer composition for amplifying a gene region having diverse variations in a target gene
11/10/2011	WO2011138966A1 Method for producing acrylamide using microbial catalyst
11/10/2011	WO2011138925A1 Nucleic acid amplifier and nucleic acid inspection device using same
11/10/2011	WO2011138891A1 Thioesterase and method for producing fatty acid or lipid using same
11/10/2011	WO2011138787A1 Identification of mrna-specific micrornas
11/10/2011	WO2011138457A1 Ucp1 (thermogenin) - inducing agents for use in the treatment of a disorder of the energy homeostasis
11/10/2011	WO2011138449A2 Antagonists of sema3e/plexind1 interaction as anti-cancer agents
11/10/2011	WO2011138423A1 Chimeric receptors and methods for identifying agents exhibiting an activity on type 1 single pass transmembrane receptors
11/10/2011	WO2011138414A1 Methods and tools for screening agents exhibiting an activity on receptors of the tumor necrosis factor receptor superfamily
11/10/2011	WO2011138392A1 Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
11/10/2011	WO2011138391A1 Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
11/10/2011	WO2011138328A2 Use of inhibitory molecules for the treatment of pulmonary hypertension
11/10/2011	WO2011138279A1 Novel antibody to a carbonic anhydrase
11/10/2011	WO2011138251A1 Lentiviral vector based immunological compounds against malaria
11/10/2011	WO2011138233A1 Method for producing recombinant proteins from plant hairy roots
11/10/2011	WO2011138054A1 Modulation of germination, elongation growth, flowering time, seed size and frost tolerance in plants
11/10/2011	WO2011138006A1 Sensors for the detection of intracellular metabolites
11/10/2011	WO2011137998A1 Brassica plants with altered architecture
11/10/2011	WO2011137687A1 Antibody against carcinoembryonic antigen and uses thereof
11/10/2011	WO2011137571A1 Human-derived neutralizing antibody rvfab5 against rabies virus glycoprotein
11/10/2011	WO2011137570A1 Human-derived neutralizing antibody rvfab8 against rabies virus glycoprotein
11/10/2011	WO2011137569A1 Humanized neutralizing antibody rvfab3 against rabies virus glycoprotein
11/10/2011	WO2011137486A1 Diagnostic and prognostic and therapeutic methods
11/10/2011	WO2011116131A3 Soybean aphid resistance gene rag2
11/10/2011	WO2011112945A3 Foot and mouth disease virus recombinant vaccines and uses thereof
11/10/2011	WO2011109427A3 Improving the biological activity of sirna through modulation of its thermodynamic profile
11/10/2011	WO2011104128A3 Plants having enhanced yield-related traits and a method for making the same
11/10/2011	WO2011101472A3 Complexes of an3-interacting proteins and their use for plant growth promotion
11/10/2011	WO2011099006A3 Enzymatic systems for carbon fixation and methods of generating same
11/10/2011	WO2011090741A3 TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
11/10/2011	WO2011090740A3 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
11/10/2011	WO2011088402A9 The use of entrained neutrophils to treat metastatic and micrometastatic disease in at risk patients
11/10/2011	WO2011088137A3 Bad pathway gene signature
11/10/2011	WO2011087760A3 Processes and kits for identifying aneuploidy
11/10/2011	WO2011087222A3 Anticancer peptide sequence
11/10/2011	WO2011085247A3 Vectors and methods for transducing b cells
11/10/2011	WO2011084772A3 Allelic disorders caused by mutations in trpv4
11/10/2011	WO2011083933A3 Mutant strain for producing l-ornithine or l-arginine, and method for producing same
11/10/2011	WO2011083464A3 Methods for use of a specific anti-angiogenic adenoviral agent
11/10/2011	WO2011082318A3 Methods and compositions for the introduction and regulated expression of genes in plants
11/10/2011	WO2011082038A3 Improved reprogramming compositions
11/10/2011	WO2011079307A3 Methods and compositions for treating neurological disorders
11/10/2011	WO2011078665A8 Improved techniques for transfecting protoplasts
11/10/2011	WO2011078495A3 Chemo-sensitive prediction method for snp
11/10/2011	WO2011076873A9 Influenza targets
11/10/2011	WO2011074897A3 Method of manufacturing reference material using plant cultured cell lines
11/10/2011	WO2011072288A3 Insulin analogues with chlorinated amino acids
11/10/2011	WO2011065715A3 Method of preparing cells susceptible to transmissible spongiform encephalopathy and the creation of tse persistently infected cells
11/10/2011	WO2011056975A3 Genetically encoded calcium indicators and methods of use
11/10/2011	WO2011039646A3 Papilloma virus -like particles for targeted gene delivery
11/10/2011	WO2011035205A3 Antibodies against candida, collections thereof and methods of use
11/10/2011	WO2007137973A8 Manipulation of the nitrogen metabolism using ammonium transporter or glucose 6-phosphate deshydrogenases or farnesyl phosphate synthetase (fpp)
11/10/2011	WO2004058052A8 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
11/10/2011	US20110277189 Mutant plant, a method for producing thereof and a method of increasing frequency of a genetic recombination
11/10/2011	US20110277188 Change in Plant Architecture
11/10/2011	US20110277187 Modification of Fructan Biosynthesis, Increasing Plant Biomass, and Enhancing Productivitiy of Biochemical Pathways in a Plant
11/10/2011	US20110277186 Modification of Flavonoid Biosynthesis in Plants
11/10/2011	US20110277185 Insecticidal proteins from bacillus thuringiensis
11/10/2011	US20110277184 Insecticidal proteins from bacillus thuringiensis
11/10/2011	US20110277183 Alteration of plant architecture characteristics in plants

1 ... 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 ... 4023